The Association of Blood-Based Inflammatory Factors IL-1β, TGF-β and CRP with Cognitive Function in Alzheimer’s Disease and Mild Cognitive Impairment

키워드

참고문헌 (59)

1. Hampel H, "The future of Alzheimer’s disease : The next 10 years", Prog Neurobiol, 95, pp.718~728 (2011)
2. Fu Y, "Protein-Based biomarkers in cerebrospinal fluid and blood for Alzheimer’s disease", J Mol Neurosci, 54, pp.739~747 (2014)
3. Alzheimer’s Association, "2013 Alzheimer’s disease facts and figures", Alzheimers Dement, 9, pp.208~245 (2013)
4. Pedro C, "Blood-based biomarkers of Alzheimer’s disease : diagnostic algorithms and new technologies", Curr Alzheimer Res, 13, pp.450~464 (2016)
5. Dubois B, "Alzheimer’s disease : from biomarkers to diagnosis", Rev Neurology, 169, pp.744~751 (2013)
6. Jose Miguel RP, "A review : inflammatory process in Alzheimer’s disease, role of cytokines", ScientificWorldJournal, 2012, pp.75637~ (2012)
7. Joachim CL, "The seminal role of β-amyloid in the pathogenesis of Alzheimer disease", Alzheimer Dis Assoc Disord, 6, pp.7~34 (1992)
8. Braak H, "Abnormally phosphorylated tau protein related to the formation of neurofibrillary tangles and neuropil threads in the cerebral cortex of sheep and goat", Neurosci Lett, 171, pp.1~4 (1994)
9. Kaduszkiewicz H, "Cholinesterase inhibitors for patients with Alzheimer’s disease : systematic revie of randomized clinical trials", BMJ, 67, pp.1757~1763 (2005)
10. Wyss-Coray T, "Inflammation in Alzheimer’s disease: driving force, bystander or beneficial response?", Nat Med, 12, pp.1005~1015 (2006)
11. Kumar V, "Robbins Basic Pathology", pp.31~58 (2007), Elsevier Health Science
12. Akiyama H, "Inflammation and Alzheimer’s disease", Neurobiol Aging, 21, pp.383~421 (2000)
13. Cacquevel M, "Cytokines in neuroinflammation and Alzheimer’s disease", Curr Drug Targets, 5, pp.529~534 (2004)
14. Boraschi D, "Mapping of receptor biding sites on IL-1 beta by reconstruction of IL1ra like domains", J Immunol, 155, pp.4719~4725 (1995)
15. Allan SM, "Interleukin-1 and neuronal injury", Nat Rev Immunol, 5, pp.629~640 (2005)
16. Sastre M, "Nonsteroidal anti-inflammatory drugs and peroxisome proliferator-activated receptor-gamma agonists modulate immune stimulated processing of amyloid precursor protein through regulation of beta-secretase", J Neurosci, 23, pp.9796~9804 (2003)
17. Licastro F, "Increased plasma levels of interlukin-1, interlukin-6 and alpha-1-antichymotrypsin in patients with Alzheimer’s disease: Peripheral inflammation or signals from the brain?", J Neuro Immunol, 103, pp.97~102 (2000)
18. Yasutake C, "Serum BDNF, TNF-alpha and IL-1 beta levels in dementia patients : comparison between Alzheimer’s disease and vascular dementia", Eur Arch Psychiatry Clin Neurosci, 256, pp.402~406 (2006)
19. Norgaard P, "Transforming growth factor beta and cancer", Cancer Treat Rev, 21, pp.367~403 (1995)
20. Lippa CF, "Transforming growth factor-beta : neuronal and glial expression in CNS degenerative disease", Neurodegeneration, 4, pp.425~432 (1995)
21. Wyss-Coray T, "Amyloidogenic role of cytokine TGF-beta 1 in transgenic mice and in Alzheimer’s disease", Nature, 389, pp.603~606 (1997)
22. Zhang X, "TGF-beta 1 factor in the cerebrovascular diseases of Alzheimer’s disease", Eur Rev Med Pharmacol Sci, 20, pp.5178~5185 (2016)
23. Chao CC, "Serum cytokine levels in patients with Alzheimer’s disease", Clin Diagn Lab Immunol, 4, pp.433~436 (1994)
24. Gabay C, "Acute phase proteins and other systemic responses to inflammation", N Engl J Med, 340, pp.448~454 (1999)
25. Duong T, "C-reactive protein like immunoreactivity in the neurofibrillary tangles of Alzheimer’s disease", Brain Res, 749, pp.152~156 (1997)
26. Hu WT, "Plasma multi analyze profiling in mild cognitive impairment and Alzheimer disease", Neurology, 79, pp.897~905 (2012)
27. Popp J, "Markers of neuroinflammation associated with Alzheimer’s disease pathology in older adults", Brain Behav Immun, 62, pp.203~211 (2017)
28. D’Anna L, "Serum interlukin-10 levels correlate with cerebrospinal fluid amyloid beta deposition in Alzheimer disease patients", Neurodegener Dis, 17, pp.227~234 (2017)
29. de Almeids SM, "Incidence of post dural puncutre headahce in research volunteers", Headache, 51, pp.1503~1510 (2011)
30. Alvarez XA, "Blood levels of histamine, IL-1β, TNF-α in patients with mild to moderate Alzheimer disease", Mol Chem Neuropathol, 29, pp.237~252 (1996)
31. Faul F, "Statistical power analyses using G*Power 3. 1 : Test for correlation and regression analyses", Behav Res Methods, 41, pp.1149~1160 (2009)
32. Petersen RC, "Mild cognitive impairment : clinical characterization and outcome", Arch Neurol, 56, pp.303~308 (1999)
33. Park JH, "Standardization of Korean Version of the MiniMental State Examination(MMSE-K)for use in the elderly", J Clin Psychiatry, 73, pp.1548~1554 (2012)
34. Morris JC, "The Clinical Dementia Rating Scale(CDR) : current version and scoring rules", Neurology, 42, pp.2412~2414 (1993)
35. Reisberg B, "Global Deterioration Scale(GDS)", Psychopharmacol Bull, 24, pp.661~663 (1988)
36. Sheikh JI, "Proposed factor structure of the Geriatric depression scale", Psychopharmacol Bull, 3, pp.23~28 (1991)
37. Bae JN, "Development of the Korean version of the Geriatric Depression scale and its short form among elderly psychiatric patients", J Psychosom Res, 57, pp.297~305 (2004)
38. Vasilakos JP, "Interleukin-1 beta dissociates beta-amyloid precursor protein and beta-amyloid peptide secretion", FEBS Lett, 354, pp.289~292 (1994)
39. Forloni G, "Expression of amyloid precursor protein mRNAs in endothelial, neuronal and glial cells : modulation by interleukin-1", Brain Res Mol Brain Res, 16, pp.128~134 (1992)
40. Licastro F, "Increased plasma levels of interleukin-1, interleukin-6 and alpha-1-antichymotrypsin in patients with Alzheimer’s disease: Peripheral inflammation or signals from the brain?", J Neuroimmunol, 103, pp.97~102 (2000)
41. Reale M, "Treatment with an acetylcholinesterase inhibitor in Alzheimer patients modulates the expression and production of the pro-inflammatory and antiinflammatory cytokines", J Neuroimmunol, 148, pp.162~171 (2004)
42. Chao CC, "Transforming growth factor beta in Alzheimer’s disease", Clin Diagn Lab Immunol, 1, pp.109~110 (1994)
43. Malaguarnera L, "Interleukin-18 and transforming growth factor-beta 1 plasma levels in Alzheimer’s disease and vascular dementia", Neuropathology, 26, pp.307~312 (2006)
44. Mocali A, "Increased plasma levels of soluble CD40, together with the decrease of TGF beta 1, as possible differential markers of Alzheimer disease", Exp Gerontol, 39, pp.1555~1561 (2004)
45. Mancinella A, "Is there a relationship between high C-Reactive Protein (CRP) levels and dementia?", Arch Gerontol Geriatr, 49, pp.185~194 (2009)
46. Tarkowski E, "Cerebral pattern of pro-and anti-inflammatory cytokines in dementias", Brain Res Bull, 61, pp.255~260 (2003)
47. Zipp F, "The brain as a target of inflammation : common pathways link inflammatory and neurodegenerative diseases", Trends Neurosci, 29, pp.518~527 (2006)
48. Hanisch UK, "Microglia as a source and target of cytokines", Glia, 40, pp.140~155 (2002)
49. Perry VH, "The impact of systemic infection on the progression of neurodegenerative disease", Nat Rev Neurosci, 4, pp.103~112 (2003)
50. Altstiel, "Cytokines in Alzheiemer’s disease", Prog Neuropsychopharmacol Biol Psychiatry, 15, pp.481~495 (1991)
51. Schrocksnadel K, "Monitoring tryptophan metabolism in chronic immune activation", Clin Chim Acta, 364, pp.82~90 (2006)
52. Fukui S, "Blood-brain barrier transport of kynurenines : implications for brain synthesis and metabolism", J Neurochem, 56, pp.2007~2017 (1991)
53. Guillemin GJ, "Indoleamine 2, 3 dioxygenase and quinolinic acid immunoreactivity in Alzheimer’s disease hippocampus", Neuropathol Appl Neurobiol, 31, pp.395~404 (2005)
54. Rahman A, "The excitotoxin quinolinic acid induces tau phosphorylation in human neurons", PLoS One, 4, pp.e6344~ (2009)
55. Widner B, "Tryptophan degradation and immune activation in Alzheimer’s disease", J Neural Transm, 107, pp.343~353 (2000)
56. Van der Wal EA, "Gomez-Pinilla, Cotman CW. Transforming growth factor-β1 is in plaques in Alzheimer and Down pathologies", Neuroreport, 4, pp.69~72 (1993)
57. Saad B, "Astrocyte-derived TGF-beta 2 and NGF differentially regulate neural recognition molecule expression by cultured astrocytes", J Cell Biol, 115, pp.473~484 (1991)
58. Bodmer S, "Transforming growth factor-beta bound to soluble derivatives of the beta amyloid precursor protein of Alzheimer’s disease", Biochem Biophys Res Commun, 171, pp.890~897 (1990)
59. Town T, "Blocking TGF-beta-Smad2", 3 innate immune signaling mitigates Alzheimerlike pathology, 2008, pp.14, 681~687

관련 논문AI추천